EARNEST Partners’s Precigen PGEN Stock Holding History

EARNEST Partners’s Portfolio PGEN Stock Details PGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-11	Closed	–	–	1221
2018 Q1	$0	Hold	11	–	–	﹤0.01%	1209
2017 Q4	$0	Buy	+11	New	+$164	﹤0.01%	1209
2017 Q1	–	Sell	-11	Closed	–	–	725
2016 Q4	$0	Buy	+11	New	+$306	﹤0.01%	1166

Other funds holding PGEN

Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

IAM

Iridian Asset Management Westport, Connecticut $291M AUM 49.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

MVP

Miller Value Partners Sarasota, Florida $423M AUM 49.14% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

EARNEST Partners's PGEN Position: Q2 2018 in Review

EARNEST Partners sold out of Precigen (PGEN) in Q2 2018, closing a stake of 11 shares.

EARNEST Partners first reported a position in PGEN in Q4 2016 and held it in 3 quarters. The position peaked at $0 in Q1 2018. 166 funds tracked by Wall St. Rank hold PGEN as of Q2 2018.

EARNEST Partners reported no remaining Precigen position as of Q2 2018 after selling out during the quarter.
EARNEST Partners sold 11 Precigen shares in Q2 2018.
EARNEST Partners first reported a position in Precigen in Q4 2016 and held it in 3 quarters.
EARNEST Partners's Precigen position peaked at $0 in Q1 2018.
166 funds tracked by Wall St. Rank held Precigen as of Q2 2018.

Based on EARNEST Partners's 13F filing for Q2 2018, filed 13 Aug 2018.